Just 14 pharmacies failed GPhC inspections for shortfalls linked to valproate since 2018/2019, figures show

摘要

Of the 6,800 pharmacy inspections carried out by the General Pharmaceutical Council (GPhC) since 2018/2019, just 14 failed because of a shortfall in relation to valproate and the pregnancy prevention programme (PPP). The GPhC said that there had been 11 fitness to practise cases during the period 2018–2021 that were linked with registrant non-compliance with the PPP. The Pharmaceutical Journal obtained the data under the Freedom of Information Act.